Fractional poisson - A simple dose-response model for human norovirus

Risk Analysis

Volumn 34, Issue 10, 2014, Pages 1820-1829

  Messner, Michael J ^a   Berger, Philip ^a   Nappier, Sharon P ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Beta Poisson; Dose response; Fractional Poisson; Immunity; Infection; Norovirus

Indexed keywords

HEALTH RISKS; RISK ASSESSMENT; VIRUSES;

BETA-POISSON; DOSE RESPONSE; FRACTIONAL POISSON; IMMUNITY; INFECTION; NOROVIRUS;

POISSON DISTRIBUTION;

NOROVIRUS;

CALICIVIRUS INFECTION; HUMAN; NOROVIRUS; PATHOGENICITY; POISSON DISTRIBUTION; VIROLOGY;

CALICIVIRIDAE INFECTIONS; HUMANS; NOROVIRUS; POISSON DISTRIBUTION;

EID: 84911991210     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/risa.12207     Document Type: Article

References (25)

1. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL. Foodborne illness acquired in the United States-Major pathogens. Emerging Infectious Diseases, 2011; 17:7-15.
2. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. Laboratory efforts to cultivate noroviruses. Journal of General Virology, 2004; 85(Part 1):79-87.
3. Matthews JE, Dickey BW, Miller RD, Felzer JR, Dawon BP, Lee AS, Rocks JJ, Kiel J, Montes JS, Moe CL, Eisenberg JNS, Leon JS. The epidemiology of published norovirus outbreaks: A review of risk factors associated with attack rate and genogroup. Epidemiology and Infection, 2012; 140:1161-1172.
4. Thebault A, Teunis PFM, Le Pendu J, Le Guyader FS, Denis J-B. Infectivity of GI and GII noroviruses established from oyster related outbreaks. Epidemics, 2012; 5:98-110.
5. Le Guyader, FS, Neill FH, Dubois E, Bon F, Loisy F, Kohli E, Pommepuy M, Atmar, RL. A semiquantitative approach to estimate Norwalk-like virus contamination of oysters implicated in an outbreak. International Journal of Food Microbiology, 2003; 87:107-112.
6. Teunis PFM, Moe CL, Pengbo L, Miller SE, Lindesmith L, Baric RS, Le Pendu J, Calderon RL. Norwalk virus: How infectious is it? Journal of Medical Virology, 2008; 80:1468-1476.
7. Seitz SR, Leon JS, Schwab KJ, Lyon GM, Dowd M, McDaniels M, Abdulhafid G, Fernandez ML, Lindesmith LC, Baric RS, Moe CL. Norovirus infectivity in humans and persistence in water. Applied and Environmental Microbiology, 2011; 77:6884-6888.
8. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Graham DY. Norwalk virus shedding after experimental human infection. Emerging Infectious Diseases, 2008; 14(10):1553-1557.
9. Reeck A, Kavanagh O, Estes MK, Opekun AR, Gilger MA, Graham DY, Atmar, RL. Serological correlate against Norovirus-induced gastroenteritis. Journal of Infectious Diseases, 2010; 202(8):1212-1218.
10. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindbland L, Stewart P, Le Pendu J, Baric R. Human susceptibility and resistance to norovirus infection, Nature Medicine, 2003; 9:548-553.
11. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Ramani S, Hill H, Ferreira J, Graham DY. Determination of the human infectious dose-50% for Norwalk virus. Journal of Infectious Diseases, 2014; 209(7):1016-1022.
12. Frenck R, Bernstein DI, Huang P, Zhong W, Parker S, Dickey M, McNeal, M, Jiang X. Predicting susceptibility to Norovirus GII.4 by use of a challenge model involving humans. Journal of Infectious Diseases, 2012; 206:1386-1393.
13. Debbink K, Lindesmith LC, Donaldson EF, Baric RS. Norovirus immunity and the great escape. Public Library of Science Pathogens, 2012; 8(10):1-5.
14. Hutson AM, Airaud F, Le Pendu J, Estes MK, Atmar RL. Norwalk virus infection associates with secretor status genotyped from sera. Journal of Medical Virology, 2005; 77:116-120.
15. Kitajima M, Haramoto E, Phanuwan C, Katayama H, Furumai H. Molecular detection and genotyping of human noroviruses in influent and effluent water at a wastewater treatment plant in Japan. Journal of Applied Microbiology, 2012; 112(3):605-613.
16. Aw TG, Gin KY. Environmental surveillance and molecular characterization of human enteric viruses in tropical urban wastewaters. Journal of Applied Microbiology, 2010; 109(2):716-730.
17. Fankhauser RL, Monroe SS, Noel JS, Humphrey CD, Bresee JS. Epidemiologic and molecular trends of ''Norwalk-like viruses'' associated with outbreaks of gastroenteritis in the United States. Journal of Infectious Diseases, 2002; 186:1-7.
18. Spiegelhalter D, Thomas A, Best N, Lunn D. WinBUGS 1.4.3 User Manual, 2007. Available at: http://www.mrc-bsu.cam.ac.uk/bugs, Accessed on February 19, 2014.
19. Albert J. Bayesian Computation with R, 2nd ed. New York: Springer, 2009.
20. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control, 1974; 19(6):716-723.
21. Le Guyader FS, Krol J, Ambert-Balay K, Ruvoen-Clouet N, Deaubliaux B, Parnaudeau S, le Saux J-C, Ponge A, Pothier P, Atmar RL, Le Pendu J. Comprehensive analysis of a Norovirus-associated gastroenteritis outbreak, from the environment to the consumer. Journal of Clinical Microbiology, 2010; 48(3):915-920.
22. U.S. EPA. National Primary Drinking Water Regulations: Long Term 2 Enhanced Surface Water Treatment Rule (LT2ESWTR); Final Rule, Federal Register (71 FR 654, January 5, 2006), 2006; 71(3):654-786.
23. Schmidt PJ, Pintar KDM, Fazil AM, Topp E. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo. Risk Analysis, 2013; 33(9):1677-1693.
24. DuPont HL, Hornick RB, Dawkins AT, Snyder MJ, Formal SB. The response of man to virulent Shigella flexneri 2a. Journal of Infectious Diseases, 1969; 119(3):296-299.
25. Ward RL, Bernstein KI, Young EC, Sherwood JR, Knowlton DR, Schiff GM. Human rotavirus studies in volunteers: Determination of infectious dose and serological response to infection, Journal of Infectious Diseases, 1986; 154(5):871-880.